Fatemeh Rezaei‐Tazangi

853 total citations
55 papers, 572 citations indexed

About

Fatemeh Rezaei‐Tazangi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Fatemeh Rezaei‐Tazangi has authored 55 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in Fatemeh Rezaei‐Tazangi's work include Mesenchymal stem cell research (10 papers), Curcumin's Biomedical Applications (7 papers) and Cancer Cells and Metastasis (6 papers). Fatemeh Rezaei‐Tazangi is often cited by papers focused on Mesenchymal stem cell research (10 papers), Curcumin's Biomedical Applications (7 papers) and Cancer Cells and Metastasis (6 papers). Fatemeh Rezaei‐Tazangi collaborates with scholars based in Iran, United States and China. Fatemeh Rezaei‐Tazangi's co-authors include Nasim Ebrahimi, Amir Reza Aref, Michael R. Hamblin, Roya Khorram, Reza Arefnezhad, Samaneh Adelian, Amir Reza Aref, Layasadat Khorsandi, Amirhossein Ahmadi and Payam Baziyar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Fatemeh Rezaei‐Tazangi

47 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemeh Rezaei‐Tazangi Iran 12 277 129 121 72 69 55 572
Shujuan Huang China 14 315 1.1× 99 0.8× 116 1.0× 73 1.0× 61 0.9× 35 699
Katarzyna Kulcenty Poland 17 377 1.4× 156 1.2× 192 1.6× 92 1.3× 67 1.0× 48 766
Kun Yan China 15 412 1.5× 131 1.0× 81 0.7× 39 0.5× 72 1.0× 31 607
Heng Zheng United States 10 243 0.9× 98 0.8× 116 1.0× 105 1.5× 63 0.9× 14 535
Longyu Jin China 14 364 1.3× 179 1.4× 90 0.7× 42 0.6× 96 1.4× 38 631
Shuang Yan China 17 466 1.7× 135 1.0× 215 1.8× 85 1.2× 72 1.0× 50 801
Yanling Sun China 13 348 1.3× 155 1.2× 124 1.0× 132 1.8× 45 0.7× 52 580
Shuangnian Xu China 17 354 1.3× 118 0.9× 131 1.1× 106 1.5× 54 0.8× 47 749
Xu Shi China 15 263 0.9× 125 1.0× 72 0.6× 135 1.9× 156 2.3× 32 677
Tao Pan China 11 315 1.1× 157 1.2× 227 1.9× 94 1.3× 122 1.8× 22 627

Countries citing papers authored by Fatemeh Rezaei‐Tazangi

Since Specialization
Citations

This map shows the geographic impact of Fatemeh Rezaei‐Tazangi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Rezaei‐Tazangi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Rezaei‐Tazangi more than expected).

Fields of papers citing papers by Fatemeh Rezaei‐Tazangi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Rezaei‐Tazangi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Rezaei‐Tazangi. The network helps show where Fatemeh Rezaei‐Tazangi may publish in the future.

Co-authorship network of co-authors of Fatemeh Rezaei‐Tazangi

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Rezaei‐Tazangi. A scholar is included among the top collaborators of Fatemeh Rezaei‐Tazangi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Rezaei‐Tazangi. Fatemeh Rezaei‐Tazangi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arefnezhad, Reza, Seyed Ali Hosseini, Amir Lotfi, et al.. (2025). Baicalin and baicalein against myocardial ischemia-reperfusion injury: A review of the current documents. Tissue and Cell. 93. 102772–102772. 1 indexed citations
3.
Chahardehi, Amir Modarresi, et al.. (2025). The Effect of Malonate as a Succinate Dehydrogenase Inhibitor on Myocardial Ischemia/Reperfusion Injury. Cell Biology International. 49(12). 1545–1563. 1 indexed citations
4.
Chahardehi, Amir Modarresi, et al.. (2025). The emerging role of circulating tumor DNA in brain tumor research. IBRO Neuroscience Reports. 18. 714–725. 3 indexed citations
5.
Arefnezhad, Reza, et al.. (2024). Umbilical cord mesenchymal stem cells and lung cancer: We should be hopeful or hopeless?. Tissue and Cell. 88. 102410–102410. 7 indexed citations
6.
Nazari, Ahmad, et al.. (2024). Does crocin create new hope for the treatment of oral problems? A focus on periodontitis. Molecular Biology Reports. 51(1). 224–224. 3 indexed citations
7.
Elahi, Mohammad, et al.. (2024). Protective Effects of Curcumin Against Medulloblastoma: A Review. Natural Product Communications. 19(4). 3 indexed citations
8.
Nazari, Ahmad, et al.. (2024). New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer. Antioxidants and Redox Signaling. ars20230491–ars20230491. 3 indexed citations
9.
Goleij, Pouya, et al.. (2024). Umbilical cord mesenchymal stem cells: A powerful fighter against colon cancer?. Tissue and Cell. 90. 102523–102523. 2 indexed citations
10.
Rezaei‐Tazangi, Fatemeh, et al.. (2024). Therapeutic Effects of Wharton’s Jelly Mesenchymal Stem Cells: from Laboratory to Clinical Application. Brazilian Archives of Biology and Technology. 67. 1 indexed citations
11.
Ebrahimi, Nasim, Fatemeh Rezaei‐Tazangi, Payam Baziyar, et al.. (2023). The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma. Environmental Research. 228. 115914–115914. 12 indexed citations
12.
Rezaei‐Tazangi, Fatemeh, et al.. (2023). Nano-based Herbal Medicine: A New Candidate for Prostate CancerTreatment?. Current Traditional Medicine. 10(7). 1 indexed citations
13.
Khodayar, Mohammad Javad, et al.. (2023). Adipose-Derived Mesenchymal Stem Cells Secretome Induces Apoptosis in Colon Carcinoma HT-29 Cells. 13(4). 2 indexed citations
14.
Ebrahimi, Nasim, Samaneh Adelian, Fatemeh Rezaei‐Tazangi, et al.. (2023). Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance. Critical Reviews in Oncology/Hematology. 182. 103920–103920. 61 indexed citations
15.
Arefnezhad, Reza, et al.. (2023). Ameliorating Effects of Curcumin on Testicular Cancer. Andrologia. 2023(1). 4 indexed citations
16.
Ebrahimi, Nasim, Roya Khorram, Fatemeh Rezaei‐Tazangi, et al.. (2023). Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences. 80(4). 104–104. 78 indexed citations
17.
Ebrahimi, Nasim, Fatemeh Rezaei‐Tazangi, Samaneh Adelian, et al.. (2022). Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer. Cellular and Molecular Life Sciences. 79(11). 572–572. 24 indexed citations
18.
Aliakbari, Fereshteh, et al.. (2021). Effect of semen washing methods on diminishing the transmission of viral infections in artificial reproductive technology. SHILAP Revista de lepidopterología. 6(2). e33–e33. 1 indexed citations
19.
Aliakbari, Fereshteh, et al.. (2021). A review of methods for preserving male fertility. Zygote. 30(3). 289–297. 10 indexed citations
20.
Rezaei‐Tazangi, Fatemeh, et al.. (2021). Secretome of adipose derived stem cells induced apoptosis in anaplastic thyroid carcinoma C-643 cells. Immunopathologia Persa. 8(1). e20–e20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026